Knockdown of Clusterin Expression Increases the In Vitro Sensitivity of Human Prostate Cancer Cells to Paclitaxel

REFERENCES

• Ammar H., and Closset, J. L. 2008. Clusterin activates survival through the phosphatidylinositol 3-kinase/Akt pathway. J. Biol. Chem. 283: 12851–12861.
   PubMed Web of Science ®Google Scholar
• Blaschuk, O., Burdzy, K., and Fritz, I. B. 1983. Purification and characterization of a cell-aggregating factor (clusterin), the major glycoprotein in ram rete testis fluid. J. Biol. Chem. 258: 7714–7720.
   PubMed Web of Science ®Google Scholar
• Bettuzzi, S., Scorcioni, F., Astancolle, S., Davalli, P., Scaltriti, M., and Corti, A. 2002. Clusterin (SGP-2) transient overexpression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progression. Oncogene 21: 4328–4334.
   PubMed Web of Science ®Google Scholar
• Biroccio, A., D’Angel, C., Jansen, B., Gleave, M. E., and Zupi, G. 2005. Antisense clusterin oligonucleotides increase the response of HER-2 gene amplified breast cancer cells to trastuzumab. J. Cell. Physiol. 204: 463–469.
   PubMed Web of Science ®Google Scholar
• Cervellera, M., Raschella, G., Santilli, G., Tanno, B., Ventura, A., Mancini, C., Sevignani, C., Calabretta, B., and Sala, A. 2000. Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB. J. Biol. Chem. 275: 21055–21060.
   PubMed Web of Science ®Google Scholar
• Chen, X., Halberg, R.B., Ehrhardt, W.M., Torrealba, J., and Dove, W. F. 2003. Clusterin as a biomarker in murine and human intestinal neoplasia. Proc. Natl. Acad. Sci. USA 100: 9530–9535.
   PubMed Web of Science ®Google Scholar
• Collard, M. W., and Griswold, M. D. 1987. Biosynthesis and molecular cloning of sulfated glycoprotein 2 secreted by rat Sertoli cells. Biochemistry 26: 3297–3303.
   PubMed Web of Science ®Google Scholar
• Dumont, P., Chainiaux, F., Eliaers, F., Petropoulou, C., Remacle, J., Koch-Brandt, C., Gonos, E. S., and Toussaint, O. 2002. Overexpression of apolipoprotein J in human fibroblasts protects against cytotoxicity and premature senescence induced by ethanol and tert-butylhydroperoxide. Cell Stress Chaperones 7: 23–35.
   PubMed Web of Science ®Google Scholar
• Hassan, M. K., Watari, H., Han, Y., Mitamura, T., Hosaka, M., Wang, L., Tanaka, S., and Sakuragi, N. 2011. Clusterin is a potential molecular predictor for ovarian cancer patient’s survival: targeting clusterin improves response to paclitaxel. J. Exp. Clin. Cancer Res. 30: 113.
   PubMed Web of Science ®Google Scholar
• Jones, S. E., and Jomary, C. 2002. Clusterin. Int. J. Biochem. Cell. Biol. 34: 427–431.
   PubMed Web of Science ®Google Scholar
• July, L. V., Beraldi, E., So, A., Fazil, L., Evans, K., English, J. C., and Gleave, M. E. 2004. Nucleotide-based therapies targeting clusterin chemosensitized human lung adenocarcinoma cells both in vitro and in vivo. Mol. Cancer Ther. 3: 223–232.
   PubMed Web of Science ®Google Scholar
• Junttila, M. R., Puustinen, P, Niemelä, M, Ahola, R., Arnold, H., Böttzauw, T., Ala-aho, R., Nielsen, C., Ivaska, J., Taya, Y., Lu, S. L., Lin, S., Chan, E. K., Wang, X. J., Grènman, R., Kast, J., Kallunki, T., Sears, R., Kähäri, V. M., and Westermarck, J. 2007. CIP2A inhibits PP2A in human malignancies. Cell 130: 51–62.
   PubMed Web of Science ®Google Scholar
• Kim, S. W., Kim, H. J., Chun, Y. J., and Kim, M. Y. 2010. Ceramide produces apoptosis through induction of p27kip1 by protein phosphatase 2A-dependent Akt dephosphorylation in PC-3 prostate cancer cells. J. Toxicol. Environ. Health A 73: 1465–1476.
   PubMed Web of Science ®Google Scholar
• Leeb, C., Eresheim, C., and Nimpf, J. 2014. Clusterin is a ligand for apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR) and signals via the Reelin-signaling pathway. J. Biol. Chem. 289: 4161–4172.
   PubMed Web of Science ®Google Scholar
• Leskov, K. S., Klokov, D. Y., Li, J., Kinsella, T. J., and Boothman, D.A. 2003. Synthesis and functional analyses of nuclear clusterin, a cell death protein. J. Biol. Chem. 278: 11590–11600.
   PubMed Web of Science ®Google Scholar
• Miyake, H., Hara, I., Gleave, M. E., and Eto, H. 2004. Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen. Prostate 61: 318–323.
   PubMed Web of Science ®Google Scholar
• Miyake, H., Hara, S., Arakawa, S., Kamidono, S., and Hara, I. 2002. Overexpression of clusterin is an independent prognostic factor for non-papillary renal cell carcinoma. J. Urol. 167: 703–706.
   PubMed Web of Science ®Google Scholar
• Miyake, H., Nelson, C., Rennie, P. S., and Gleave, M. E. 2000. Testosterone expressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer. Cancer Res. 60: 170–176.
   PubMed Web of Science ®Google Scholar
• Perrotti, D., and Neviani, P. 2013. Protein phosphatase 2A: A target for anticancer therapy. Lancet Oncol. 14: e229–e238.
   PubMed Web of Science ®Google Scholar
• Petropoulou, C., Trougakos, I. P., Kolettas, E., Toussaint, O., and Gonos, E. S. 2001. Clusterin/apolipoprotein J is a novel biomarker of cellular senescence that does not affect the proliferative capacity of human diploid fibroblasts. FEBS Lett. 509: 287–297.
   PubMed Web of Science ®Google Scholar
• Ranney, M. K., Ahmed, I. S. A., Potts, K. R., and Craven, R. J. 2007. Multiple pathways regulating the anti-apoptotic protein clusterin in breast cancer. Biochim. Biophys. Acta 1772: 1103–1111.
   PubMed Web of Science ®Google Scholar
• Redondo, M., Villar, E., Torres-Munoz, J., Tellez, T., Morell, M., and Petito, C. K. 2000. Overexpression of clusterin in human breast carcinoma. Am. J. Pathol. 157: 393–399.
   PubMed Web of Science ®Google Scholar
• Rizzi, F., and Bettuzzi, S. 2008. Targeting clusterin in prostate cancer. J. Physiol. Pharmacol. 59: 265–274.
   PubMed Web of Science ®Google Scholar
• Shannan, B., Seifert, M., Leskov, K., Willis, J., Boothman, D., Tilgen, W., and Reichrath, J. 2006. Challenge and promise: Roles for clusterin in pathogenesis, progression and therapy of cancer. Cell Death Differ. 13: 12–19.
   PubMed Web of Science ®Google Scholar
• Shim, J. H., Choi, C. S., Lee, E. C., Kim, M. Y., and Chun, Y. J. 2009. Tamoxifen suppresses clusterin level through Akt inactivation and proteasome degradation in human prostate cancer cells. Biomol. Ther. 17: 25–31.
   Web of Science ®Google Scholar
• So, A., Sinnemann, S., Huntsman, D., Fazli, L., and Gleave, M. 2005. Knockdown of the cytoprotective chaperone, clusterin, chemosensitizes human breast cancer cells both in vitro and in vivo. Mol. Cancer Ther. 4: 1837–1849.
   PubMed Web of Science ®Google Scholar
• Sowery, R. D., Hadaschik, B. A., So, A. I., Zoubeidi, A., Fazli, L., Hurtado-Coll, A., and Gleave, M. E. 2008. Clusterin knockdown using the antisense oligonucleotide OGX-11 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapy. Br. J. Urol. Int. 102: 389–397.
   Google Scholar
• Steinberg, J., Oyasu, R., Lang, S., Sintich, S., Rademaker, A., Lee, C., Kozlowski, J. M., and Sensibar, J. A. 1997. Intracellular levels of SGP-2 (clusterin) correlate with tumor grade in prostate cancer. Clin. Cancer Res. 3: 1707–1711.
   PubMed Web of Science ®Google Scholar
• Trougakos, I. P., Djeu J. Y., Gonos E. S., and Boothman, D. A. 2009. Advances and challenges in basic and translational research on clusterin. Cancer Res. 69: 403–406.
   PubMed Web of Science ®Google Scholar
• Trougakos, I. P., Lourda, M., Agiostratidou, G., Kletsas, D., and Gonos, E. S. 2005. Differential effects of clusterin/apolipoprotein J on cellular growth and survival. Free Radical Biol. Med. 38: 436–449.
   PubMed Web of Science ®Google Scholar
• Trougakos, I. P., So, A., Jansen, B., Gleave, M. E., and Gonos, E. S. 2004. Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress. Cancer Res. 64: 1834–1842.
   PubMed Web of Science ®Google Scholar
• Valdiglesias, V., Fernández-Tajes, J., Costa, C., Méndez, J., Pásaro, E., and Laffon, B. 2012. Alterations in metabolism-related genes induced in SHSY5Y cells by okadaic acid exposure. J. Toxicol. Environ. Health A 75: 844–856.
   PubMed Web of Science ®Google Scholar
• Wilson, M. R., and Easterbrook-Smith, S. B. 2000. Clusterin is a secreted mammalian chaperone. Trends Biochem. Sci. 25: 95–98.
   PubMed Web of Science ®Google Scholar
• Zellweger, T., Chi, K., Miyake, H., Adomat, H., Kiyama, S., Skov, K., and Gleave, M. E. 2002. Enhanced radiosensitivity in prostate cancer by inhibition of the cell survival protein clusterin. Clin. Cancer Res. 8: 3276–3284.
   PubMed Web of Science ®Google Scholar
• Zhang, H., Kim, J.K., Edwards, C.A., Xu, Z., Taichman, R., and Wang, C. Y. 2005. Clusterin inhibits apoptosis by interacting with activated Bax. Nat. Cell Biol. 7: 909–915.
   PubMed Web of Science ®Google Scholar